TMDX - Company ID 0001756262
TransMedics Group, Inc. trades as TMDX and has a market capitalization of $2.51 B, making it the #1976 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $605.49M, up 37.1% from the prior year and net income of $190.30M. This page tracks TransMedics Group, Inc. through 615 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
2026-07-09
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Next research step
Over the last 7 fiscal years TransMedics Group, Inc.'s revenue grew from $13.02M to $605.49M, a compound annual growth rate of 73.1%. Net profit margin expanded from -182.5% to 31.4% over the same period - every figure below comes from the company's audited annual filings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| Insider trade | 4 | 2026-05-22 |
| Insider trade | 4 | 2026-05-22 |
| Insider trade | 4 | 2026-05-22 |
| Insider trade | 4 | 2026-05-22 |
| Insider trade | 4 | 2026-05-22 |
| Insider trade | 4 | 2026-05-22 |
| Insider trade | 4 | 2026-05-22 |
| Insider trade | 4 | 2026-05-21 |
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | TransMedics
TransMedics to Present at the William Blair 46th Annual Growth Stock Conference | TransMedics
TransMedics Reports First Quarter 2026 Financial Results | TransMedics
TransMedics Group Announces Intent to Create the First Dedicated European Transplant Logistics Network with Strategic Investment in PAD Aviation service GmbH | TransMedics
TransMedics to Provide Update on Ongoing Clinical Programs at the International Society of Heart and Lung Transplantation 2026 Annual Meeting | TransMedics
The largest companies sharing TransMedics Group, Inc.'s SEC industry classification (electromedical & electrotherapeutic apparatus).
TransMedics Group, Inc. (TMDX) has a market capitalization of $2.51 B as of 2026-07-09, ranking #1976 among US-listed companies.
TransMedics Group, Inc. reported revenue of $605.49M for fiscal year 2025, an increase of 37.1% year over year.
Yes. TransMedics Group, Inc. reported net income of $190.30M in its latest fiscal year.